Discover reviews, ratings, and trailers for Kaiju No. 8: Mission Recon on Rotten Tomatoes. Stay updated with critic and audience scores today!

Session ID: 2025-07-01:c3d96494478f7322ba15e67b Player Element ID: Vd5cd1b33_dfb7_4cb6_a47a_a289603d2ac9_6374240200112 ...

The DXd ADC portfolio currently consists of ENHERTU ®, a HER2 directed ADC, and DATROWAY ®, a TROP2 directed ADC, which are being jointly developed and commercialized globally with AstraZeneca.

Interim results from the DESTINY-Breast-09 trial, presented at ASCO Annual Meeting, suggest trastuzumab deruxtecan (T-DXd; Enhertu; AstraZeneca, Daiichi Sankyo) plus pertuzumab (Perjeta, Genentech ...

Drs Kathryn J. Ruddy and Elizabeth J. Cathcart-Rake discuss approaches to reduce the toxicities of systemic cancer therapy and improve patient communication and the survivorship experience.

Understanding Lung Cancer PGA Tour winner Steve Pate has taken time off from work to battle a type of lung cancer called squamous cell carcinoma—a disease he was diagnosed with after struggling with ...

Enhertu is approved in the U.S. to treat certain breast, lung and gastric cancers, with 2024 sales from both companies topping $3.7 billion.